T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

Compounded copycat drugs containing tirzepatide, many sold by online pharmacies, will no longer be allowed. Semaglutide, the main ingredient in Ozempic and Wegovy, is in ongoing shortage ...

Novo Nordisk stock falls as Medicare selects its marketed semaglutide medicines catering to T2D and obesity for price ...